Cognizant (CTSH) Misses Q2 EPS by 1c, Beats on Revenue; Offers FY26 EPS Guidance
Tweet
Share
E-mail
Get Alerts CTSH Hot Sheet
Price: $60.14 -3.48%
Revenue Growth %: +4.2%
Financial Fact:
Interest income: 27.2M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +4.2%
Financial Fact:
Interest income: 27.2M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Cognizant (NASDAQ: CTSH) reported Q2 EPS of $1.37, $0.01 worse than the analyst estimate of $1.38. Revenue for the quarter came in at $5.5 billion versus the consensus estimate of $5.49 billion.
GUIDANCE:
Cognizant sees FY2026 EPS of $5.70-$5.82, versus the consensus of $5.71.
For earnings history and earnings-related data on Cognizant (CTSH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle (ORCL) call put ratio 2.3 calls to 1 put with a focus on October calls into quarter results
- CANEX Increases Equity Financing to C$9 Million
- Mizuho Defends Sarepta Therapeutics (SRPT)
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
